We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.00 | 3.45% | 300.00 | 294.00 | 299.00 | 303.00 | 298.00 | 299.00 | 53,971 | 15:51:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/5/2021 21:06 | Oh dear....well those pension fund managers will be rather displeased that their well researched 'private' equity purchases are 20% down at a flick of a cow's tail. | steeplejack | |
12/5/2021 07:30 | Nothing new came out of the fireside chat, nothing of any importance, just the teenage BoA Analayst asking a few dull pre-scripted questions. | nerdofsteel | |
11/5/2021 18:00 | 336/- shares traded in London is ,at a cursory glance, the second highest daily volume in the last twelve months.Whether that signals a sea change of sorts might become clearer as the week progresses. | steeplejack | |
11/5/2021 14:49 | First quarter of last year, the share price was sub £3 for few weeks and had recovered well. Anyone watching the ‘fire side chat’, please update the important points here. | sportii | |
11/5/2021 07:07 | I suspect its too late to sell.There's a risk that frustration sees you throw the baby out with the bathwater.I'm sure those pension funds that purchased stock around $30,some 20% above current prices will be seeking reassurance.The biotechs have been slammed of late,The problems of the ARK fund with its specialist tech holdings is reviewed in the FT today drawing attention to a fall in the fund of around 30% from its Feb peak.There's been migration into the cyclicals,crytos and miners that has hit stocks like HutchMed disproportionately. As ever the difficulty lies in whether you ride it out or follow the trend and lose patience.Like most here i suspect,i try to think long term but,of course,thats not what the market protagonists like to encourage,they hope you'll to make multi deals everyday chasing algorithms. | steeplejack | |
11/5/2021 07:06 | indeed miti, my eror was assuming that the rapid rise from 2014 to 2018 would not run out of steam given the huge progress the Company has made. | nerdofsteel | |
11/5/2021 06:43 | Nerdofsteel , A lot of biotech stocks are tanking at the moment. Rather than panic , hold your nerve until the company announces some newsflow which you don't like and then sell, if you must. Just cos the share price is falling doesn't seem like a sensible reason to me. As , I've said in the past, the only negative about HCM is that the AZN/SAVO news a few years ago was a good reason to sell the news and no idea why posters on here didnt recognise it as such. Problem was that was the blockbuster hope and that stalled and concerns have not alleviated . Still at this price HCM has other indications that have developed plus the big 100mill investment from a respected fund. Along with that we could have a HK float in the next year. The share price now is near support levels so all in all, I've started buying in , for the 1st time in a few years. just a small 7k buy at the close but I'll average down if necessary . I made a lot of money on HCM on it last time, as you know. Value will out at some point. Ride it out is my advice. | miti 1000 | |
11/5/2021 00:52 | SELLING THE LOT TOMORROW HAD ENOUGH OF THE LOSSES - been invested here for years but now running out of patience What's the saying about patience? If the company is doing well (anything to say it isn't?) the numbers will do the talking and a re-rate will follow. I can see what everyone is saying about opportunity cost and fully agree, but selling out now might be followed by regret when the bounce (hopefully!) follows. We know that the US team are about to start their drive in force and a new product is imminent. Elunate has been doing well. In the long term their other novel products will hopefully do well too. | lauders | |
10/5/2021 23:55 | NoS, Whole sector is down. Even if you want to sell do it in a rational way. Good luck , | dbadvn | |
10/5/2021 22:59 | I've always felt that you know a good deal more about this company than the rest of us here or most certainly me.I've retained a holding in my trading fund here for no other reason that i'm reluctant to throw in the towel when the company would appear to be ploughing its farrow albeit in a most pedestrian manner with the scantiest of regards to the clear under appreciation of its efforts by equity markets.It's a tricky one because we've all held stocks which have remained undervalued for yonks and then all at once,the markets seem to wake up to the potential.Thereagain | steeplejack | |
10/5/2021 19:31 | SELLING THE LOT TOMORROW HAD ENOUGH OF THE LOSSES - been invested here for years but now running out of patience | nerdofsteel | |
10/5/2021 19:15 | Creeping back up; now $25.15. Support at $25.38. Might be an up day tomorrow!! | mcmather | |
10/5/2021 18:38 | down again | nerdofsteel | |
10/5/2021 18:02 | why haven't they done a Beigene and used their new salesforce to market other non-Chinese pharma drugs? They are too conservative. | nerdofsteel | |
10/5/2021 18:01 | timbeeeerrrrrrrrrrrr | nerdofsteel | |
10/5/2021 17:59 | The management had many opportunities, viz, announcement of Chinese approval for two of their drug candidates, marketing of Fruquintinib / Surufatinib , news of partnerships with other pharmas, announcement of major investments by big institutional investors etc., for timing their Asian listing. Shame, they could not exploit the favourable market conditions. Hopefully, something good will be announced tomorrow in the investors conference. | sportii | |
10/5/2021 17:27 | I had hoped an Asian listing would be the way forward, which would get around the anti-chinese sentiment in the U.S. | nerdofsteel | |
10/5/2021 17:24 | "A Chinese climbing team is currently heading to the top of Mount Everest, to create a "line of separation" at the summit. This is to prevent climbers arriving from China and Nepal congregating together and potentially spreading Covid, as reported by the official state news agency Xinhua."Doesn't exactly encourage US institutions to dash out and top up their Chinese investment holdings with all this uncertainty over Taiwan,trade relations etc.History shows that the passing of the baton of world leadership from one power to another has rarely gone smoothly.HCM hasn't helped itself to buck a pretty broad disillusionment with Chinese investments just now.Be interesting to see the response to these investor conferences. | steeplejack | |
10/5/2021 17:16 | I may also look to reduce at some point , just a shame we have been left to think this way. | its the oxman | |
10/5/2021 17:14 | May be cut the position in half, it's worked well for me in the past. Frustrating thing here is that in many ways the co continues to deliver. But appreciate its no help if market is not impressed or interested in placing any value upon it. | its the oxman | |
10/5/2021 17:02 | I may see whether I pickup anything from the fireside chat, but unlikely. I want to remain invested but the opportunity cost is becoming unbearable which is a shame because I know the Board, I know the Company and I've been invested here for a number of years. | nerdofsteel | |
10/5/2021 16:58 | Sorry to hear that but also understandable. Hope you might retain a holding of some size and stay on the board. All the best. | its the oxman | |
10/5/2021 16:35 | The fireside chat needs to be preceded by an RNS that says something otherwise people will lose patience. I've made a lot of money here and LOST all of my gains by remaining invested because I like the Company and I think it has a great future, but there's a limit to the losses and the opportunity cost one can stomach. If I'd banked my gains and invested in an S&P500 tracker or in FAANG I'd have more than doubled my money instead of losing all my gains. I've decided to sell tomorrow. | nerdofsteel | |
10/5/2021 16:09 | Despite the proposed, "fireside chat" tomorrow which may be full of good cheer, this has started to smell rather ominously. I had the same pungent aroma given off by the likes of Paysafe and Hurricane and look what happened to them.No, I've just had enough of this one.GOOD LUCK EVERYONE! | fionascott1234 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions